Pathophysiology of hypertension in renal failure

Seminars in Nephrology

Volumn 22, Issue 1, 2002, Pages 17-26

  Salem, Mahmoud M ^a  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOREGULATION; BLOOD PRESSURE REGULATION; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; HYPERVOLEMIA; KIDNEY FAILURE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SODIUM EXCRETION; SYMPATHETIC TONE; VASCULAR RESISTANCE; VASOCONSTRICTION; WATER RETENTION;

ANEMIA; ANIMALS; BLOOD VOLUME; CARDIAC OUTPUT; GLOMERULAR FILTRATION RATE; HEMODYNAMIC PROCESSES; HUMANS; HYPERPARATHYROIDISM; HYPERTENSION; KIDNEY FAILURE, CHRONIC; NITRIC OXIDE; PROSTAGLANDINS; RENIN-ANGIOTENSIN SYSTEM; RISK FACTORS; SODIUM; SYMPATHETIC NERVOUS SYSTEM; VASCULAR RESISTANCE;

EID: 0036143246     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (78)

1. Arterial pressure regulation. Overriding dominance of the kidneys in long-term regulation and in hypertension
2. Natural history of hypertension in renal parenchymal disease
3. Hypertension in autosomal dominant polycystic kidney disease
4. Infection-related chronic interstitial nephropathy
5. Secondary hypertension in a blood pressure clinic
6. Hypertension in the hemodialysis population: A survey of 649 patients
7. Report on management of renal failure in Europe, XXII, 1991
8. Hypertension is not adequately controlled in hemodialysis patients
9. Blood pressures in hemodialysis and peritoneal dialysis using ambulatory blood pressure monitoring
10. Prevalence of hypertension in patients on peritoneal dialysis: Results of an Italian multicentre study
11. How reproducible is diurnal blood pressure rhythm in patients with secondary (renal) hypertension?
12. Prevalence of hypertension in a hemodialysis population
13. Hypertension in adults with idiopathic glomerulonephritis and normal serum creatinine. A report from the MRC Glomerulonephritis Registry
14. Hypertension caused by salt loading in the dog. 3. Onset transients of cardiac output and other circulatory variables
15. Extracellular volume in patients with chronic renal disease treated for hypertension by sodium restriction
16. Enhanced end-organ responsiveness of the uremic kidney to the natriuretic factor
17. Hypertension in chronic idiopathic glomerulonephritis: Analysis of 311 biopsied patients
18. Effects of loop diuretics on angiotensin II-stimulated vascular smooth muscle cell growth
19. The loop diuretic torasemide interferes with endothelin-1 actions in the aorta of hypertensive rats
20. Relationship of angiotensin II, aldosterone, arginine vasopressin, adrenaline and noradrenaline in plasma, blood and extracellular volumes to blood pressure in chronic glomerulonephritis
21. Hypertension associated with early stage kidney disease. Complementary roles of circulating renin, the body sodium/volume state and duration of hypertension
22. Plasma volume and chronic hypertension. Relationship to arterial pressure levels in different hypertensive diseases
23. Effects of hypervolemia on interdialytic hemodynamics and blood pressure control in hemodialysis patients
24. Survival as an index of adequacy of dialysis
25. Treatment of hypertension in dialysis patients by ultra filtration: Role of cardiac dilatation and time factor
26. Factors associated with inadequate blood pressure control in hypertensive hemodialysis patients
27. Elevated 24-hour blood pressure in peritoneal dialysis patients with ultra filtration failure
28. Renin and body fluid volumes in chronic renal disease. Relations between arterial pressure, plasma renin activity, blood volume, and extracellular volume in chronic renal disease, as compared with essential hypertension
29. Blood pressure and body water distribution in chronic renal failure patients
30. Blood pressure control in dialysis patients: Importance of the lag phenomenon
31. Hypertension in chronic hemodialysis patients: Current view on pathophysiology and treatment
32. Fluid state and blood pressure control in patients treated with long and short haemodialysis
33. Normal renin uremic hypertension. Study of cardiac hemodynamics, plasma volume, extracellular fluid volume, and the renin angiotensin system
34. Hemodynamics of hypertension in chronic end-stage renal disease
35. Blood pressure regulation in end-stage renal disease and anephric man
36. Studies on experimental hypertension. 1. The production of persistent elevation of systolic blood pressure by means of renal ischemia
37. Plasma renin activity (PRA) and aldosterone (PA) in patients with chronic glomerulonephritis (GN) and hypertension
38. Hypertension in chronic renal failure. An abnormal relation between sodium and the renin-angiotensin system
39. Renin secretion in renal hypertension
40. Hypertension in terminal renal failure
41. Norepinephrine and renin activity in chronic renal failure. Evidence for interacting roles in hemodialysis hypertension
42. Effect of continuous ambulatory peritoneal dialysis on blood pressure control
43. Angiotensin-converting enzyme gene polymorphism in haemodialysis patients
44. Angiotensin and the renal circulation in hypertension
45. Intrarenal renin-angiotensin system in renal physiology and pathophysiology
46. Autonomic blockade and the Valsalva maneuver in patients on maintenance hemodialysis: A hemodynamic study
47. Supervised atenolol therapy in the management of hemodialysis hypertension
48. Survival and predictors of death in dialysed diabetic patients
49. Patients without kidneys from up to 17 years: Bilateral nephrectomy a significant factor in long-term survival, along with lower blood pressure, female gender and younger age
50. Bilateral nephrectomy for hypertension in patients with chronic renal failure on a dialysis program
51. The kidney and the neurogenic control of blood pressure in renal disease
52. Sympathetic overactivity in patients with chronic renal failure
53. Pharmacokinetics of bisoprolol and its effect on dialysis refractory hypertension
54. Antihypertensive treatment with a vasodilating beta-blocker, carvedilol, in chronic hemodialysis patients
55. Uncontrollable hypertension in patients on hemodialysis: Long-term treatment with captopril and salt subtraction
56. Cardiac disease in chronic uremia: Pathogenesis
57. Hyperparathyroidism, platelet intracellular free calcium and hypertension in chronic renal failure
58. Effects of hypercalcemia and parathyroid hormone on blood pressure in normal and renal-failure rats
59. Vasodilation mediated by human PTH 1-34 in the spontaneously hypertensive rat
60. Hypertension secondary to early-stage kidney disease: The pathogenetic role of altered cytosolic calcium (Ca2+) homeostasis of vascular smooth muscle cells
61. Indices of activity of the nitric oxide system in hemodialysis patients
62. Nitric oxide production is low in end-stage renal disease patients on peritoneal dialysis
63. Plasma from ESRD patients inhibits nitric oxide synthase activity in cultured human and bovine endothelial cells
64. Increased reduction of dimethylarginines and lowered interdialytic blood pressure by the use of biocompatible membranes
65. Reduced production of nitric oxide during haemodialysis
66. Hyperhomocysteinemia, vascular pathology, and endothelial dysfunction
67. Effect of a hemodialysis session on plasma levels of endothelin-1 in hypertensive and normotensive subjects with end-stage renal failure
68. Biphasic changes in nitric oxide generation in hemodialyzed patients with end-stage renal disease treated with recombinant human erythropoietin
69. Erythropoietin and arterial hypertension
70. Effects of normal hematocrit on ambulatory blood pressure in epoetin-treated hemodialysis patients with cardiac disease
71. Equal levels of blood pressure control in ESRD patients receiving high-efficiency hemodialysis and conventional hemodialysis
72. Mechanisms of hypertension and kidney disease in obesity
73. The role of size at birth and postnatal catch-up growth in determining systolic blood pressure: A systematic review of the literature
74. Nephron mass as a risk factor for progression of renal disease
75. In vitro assay for a humoral substance present during volume expansion and uraemia
76. Role of increased oxygen free radical activity in the pathogenesis of uremic hypertension
77. Prevalence and significance of hypertension in systemic lupus erythematosus
78. Renal hemodynamics and the renin-angiotensin-aldosterone system in normotensive subjects with hypertensive and normotensive parents